Monday 30 June 2014

Ambulance Services Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

According to a new market report published by Transparency Market Research "Ambulance Services Market (By Mode of Transport - Ground Ambulance Services, Air Ambulance Services and Water Ambulance Services, By Emergency Type - Emergency Ambulance Services and Non-Emergency Ambulance Services and By Equipment Type - Advance Life Support (ALS) Ambulance Services and Basic Life Support (BLS) Ambulance Services) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," in the year 2012, the global Ambulance Services market was valued at USD 17.00 billion and is expected to grow at a CAGR of 8.3% during the forecast period 2013 to 2019 to reach a market value of USD 29.78 billion by 2019.


Browse the full Ambulance Services Market report at http://www.transparencymarketresearch.com/ambulance-services-industry.html


Ambulance is utilized for the transport of patients to and from hospitals for their medical treatment. The services that are provided include monitoring via various medical equipment and basic treatments by emergency medical technician (EMT). Ambulance services are extensively utilized at war fronts to rescue injured patients. The global market for Ambulance Services has been estimated to grow at the rate of 8.3% during the forecast period from 2013 to 2019. The growth of ambulance services market is primarily attributed to consistent rise in geriatric population since elderly people are more susceptible to various diseases that generate frequent need for their visit to hospitals for medical checkups and treatment. Favorable reimbursement scenario for availing ambulance services is further expected to augment the growth of this market. Likewise, increasing incidences of accidents across the globe is also anticipated to propel the demand for ambulance services.




The report on ambulance services describes several modes of transport that are utilized for patient transportation, amongst which ground ambulance services market accounted for the largest share (over 75%) by revenue of the total market. The growth of this market is also expected to exhibit impressive growth rate of 8.3% during the forecast period. Ground ambulance services are the most widely utilized mode of patient transport that results in high revenue generation. Also, majority of the ambulance service providers are engaged in providing ground ambulance services which further enhances the revenue share. Air ambulance services is the second largest segment that utilizes services due to increase in medical tourism in developing nations such as Thailand and India.


Browse Energy & Mining Market Research Reports @ http://www.transparencymarketresearch.com/energy-market-reports-3.html


Emergency ambulance services market accounted for the largest share by revenue in 2012 and is estimated to grow at the highest CAGR during the study period. This growth is attributed to improving reimbursement policies for emergency ambulance services coupled with increasing number of emergency medical hospitalizations. Similarly, based on the equipment type market for ALS ambulance services accounted for the largest share in terms of revenue in 2012 and is estimated to grow at the highest CAGR of 8.5% throughout the forecast period from 2013 to 2019. High level medical equipment such as incubators and cardiac monitoring system are installed in ALS ambulance that facilitates better medical assistance while transporting patient. This results in escalated demand for ALS ambulance services in emergency cases and in turn supports the growth of this market. Geographically, North America accounted for the largest share in terms of revenue of the total market for ambulance services in 2012. This dominance is majorly witnessed due to the presence of large number of elderly people. Presence of large number of major players of the market in this region which facilitates easy penetration also contributed in recording the largest share of the market. Owing to rise in disposable income coupled with increasing healthcare expenditure, Asia-Pacific region has been estimated to foresee the highest growth during the forecast period. The global ambulance services market is dominated by Envision Healthcare Corporation, Falck A/S, Rural/Metro Corporation, Air Methods Corporation and Acadian Ambulance Service.

Friday 27 June 2014

Prenatal, Fetal and Neonatal Equipment Market in 2013-2019: Transparency Market Research

According to a new market report published by Transparency Market Research "Prenatal, Fetal and Neonatal Equipment Market (Prenatal & Fetal Equipment: Ultrasound & Ultrasonography, Fetal Dopplers, Fetal MRI and Fetal Monitors; Neonatal Equipment: Infant Warmers & Incubators, Phototherapy Equipment, Neonatal Monitoring & Respiratory Assistance & Monitoring Devices; and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global prenatal, fetal and neonatal equipment market was valued at USD 5.89 billion in 2012 and is expected to grow at a CAGR of 6.1% from 2013 to 2019, to reach an estimated value of USD 8.92 billion in 2019.


Browse the full Prenatal, Fetal and Neonatal Equipment Market report at http://www.transparencymarketresearch.com/prenatal-fetal-neonatal-equipment-market.html


Prenatal, fetal and neonatal care is gaining importance every year with increasing awareness, demand and affordability for the latest, improved and technologically advanced equipment that are available worldwide. Premature birth has been one of the leading causes of neonatal death globally, that kills more than 1 million newborns every year. There are approximately 15 million premature babies born every year across the globe that require urgent medical attention and intensive care, which creates the demand for neonatal care equipment. Prenatal, fetal and neonatal care equipment are also required for numerous other applications, such as treatment for hypothermia, jaundice management, fetal and neonatal monitoring, respiratory assistance and others. New and technologically advanced equipment in the prenatal, fetal and neonatal equipment market will further provide growth opportunities to this market in future.




Some of the major prenatal, fetal and neonatal equipment available in the global market are ultrasound & ultrasonography, fetal dopplers, infant warmers & incubators, phototherapy equipment, and respiratory assistance & monitoring devices. Among these, respiratory assistance and monitoring devices are the largest sub-segment with over 40% share of the neonatal equipment market. The key factor responsible for the growth of the prenatal, fetal and neonatal equipment market is increasing incidences of premature births worldwide. Africa and Asia are the largest contributors towards the premature newborns, with Africa exhibiting highest incidence rate of premature births, which was 12% of the overall births in the region in 2005. However, the U.S. exhibits the second highest incidence rate of premature births with 10.6% of all births in the region in 2005. The premature babies often require urgent medical attention and thus, require various neonatal care equipment. Increasing age of maternal population is also leading to a number of complications that require various prenatal, fetal and neonatal care equipment. Rising awareness levels along with increasing affordability of the population especially in the emerging economies will further help the growth of this market in future. Increasing demand for improved and technologically advanced equipment such as double walled closed incubators, highly portable fetal dopplers will further add to the growth of this market.




North America dominates the global prenatal, fetal and neonatal equipment market, with more than 30% share in 2012 in terms of revenue, followed by the European market (over 25%). Major factors contributing to the leading position of the North American market are high incidence rate of premature births, increasing age of maternal population and high level of awareness, demand and affordability for various prenatal and neonatal care equipment in the region. Asia-Pacific is expected to show the highest CAGR of 7.8% during the forecast period from 2013 to 2019 in the global prenatal, fetal and neonatal equipment market. Key factors responsible for the region's high growth rate will be high incidence rate of premature births, high birth rate, increasing awareness and affordability of the population and rising demand for advanced equipment and devices for prenatal and neonatal care.


Thursday 26 June 2014

Infusion Pumps Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

According to a new market report published by Transparency Market Research "Infusion Pumps Market (Large Volume, Disposable, Syringe, Ambulatory and Implantable) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global infusion pumps market was valued at USD 5.4 billion in 2012 and is expected to grow at a CAGR of 5.3% from 2013 to 2019, to reach an estimated value of USD 7.8 billion in 2019.
Infusion pumps are used to deliver therapeutic drugs and fluids such as plasma, dextrose and saline solutions,into a patient's body at a precisely controlled rate. These devices are efficiently used for infusion through several routes of administration such as intravenous, epidural, arterial, subcutaneous, peritoneal, enteral and intrathecal. The use of these pumps during treatment of several indications such as diabetes, chemotherapy and in pain management has helped the infusion pumps market to grow in the past decade. With the increasing burden of these diseases across the globe, the market is expected to witness significant growth in the near future.


Browse Global Infusion Pumps Market Report with Full TOC at http://www.transparencymarketresearch.com/infusion-systems-market.html


A large segment of the global population suffering from diseases such as cancer, diabetes and chronic pain is a major driver for growth of the global infusion pumps market. The demand for more advanced infusion systems from developed nations such as the U.S., Canada, the U.K., France, Germany, Australia, Japan and Singapore is likely to serve as a good opportunity for leading players in the market. However, the quantum growth in infusion pumps market is expected to be driven by developing countries such as India and China which have a large population base and increasing attention towards healthcare infrastructure.
The global infusion pumps market has been segmented on the basis of product types, channel types, application areas, and geographic regions. On the basis of type of device, the market is divided into large volume infusion pumps, disposable infusion pumps, syringe infusion pumps, ambulatory infusion pumps and implantable infusion pumps. In 2012, large volume infusion pumps accounted for the largest share by revenue of the global infusion pumps market followed by disposable infusion pumps. Large volume infusion pumps form the largest product segment in the market due to several advantages such as many application areas, higher accuracy in infusions, wider infusion time range, dose calculation software and the recent trend of wireless integration of infusion data for electronic medical records.




The report also provides market estimations for application areas where these pumps are being used. The market has been categorized on the basis of application areas into five major segments, namely, clinical nutrition, chemotherapy, analgesia, diabetes and others. In 2012, the clinical nutrition segment shared 31.9% of the global infusion pumps market revenue. The incidence rate of diabetes in the world is increasing, particularly in the affluent countries, and this would significantly drive the market for infusion pumps used in diabetes.

Browse all Medical Devices Market Research Reports @ http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html

Geographically, North America was the largest market for infusion devices in 2012 and contributed 44.0% of the global infusion pumps market revenue in the same year. The government initiatives and provision in federal laws such as Patient Care and Affordable Care Act (PPACA) and the Health Information Technology for Economic and Clinical Health (HITECH) Act are further propelling the market. There is an increasing demand for 'smart' infusion pumps in this region and therefore North America shall maintain its leadership in the global infusion pumps market. During the forecast period 2013 to 2019, Asia-Pacific region is expected to grow at a much faster rate than other regions majorly due to the large patient base and increasing incidences of diabetes and cancer. The magnitude of malnutrition in this region is very high which is expected to trigger the demand for infusion pumps for clinical nutrition. Additionally, a significant rise in healthcare expenditure of developing economies such as China and India will continue to boost the demand for infusion pumps in this region.
The global infusion pumps market is dominated by a few major players such as CareFusion Corporation, Hospira, Inc., Baxter International, Inc., Fresenius Kabi AG, B. Braun Melsungen AG, and Terumo Corporation. Several product recalls by the prominent players as well as small companies in the market have deterred the market growth to some extent.

Wednesday 25 June 2014

Sterilization Equipment and Disinfectants Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

According to a new market report published by Transparency Market Research "Sterilization Equipment and Disinfectants Market (By Sterilization Equipment Type -Heat Sterilization, Low Temperature Sterilization, Filtration Sterilization and Radiation Sterilization,By Disinfectants Type-Low, Intermediate and High level and Oxidizing and Non-Oxidizing and By Applications- Medical Devices, Pharmaceuticals and Life-Sciences) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019,"in 2012, the global Sterilization Equipment and Disinfectants marketwas valued at USD 5.13 billion and is expected to grow at a CAGR of 8.5% during the forecast period 2013 to 2019 to reach a market value of USD 9.15 billion by 2019.


Browse Global Sterilization Equipment and Disinfectants Market Report with Full TOC at http://www.transparencymarketresearch.com/sterilization-equipment-market.html


Sterilization equipment and disinfectants are utilized to sterile various medical instruments, laboratory equipment and pharmaceutical components. Sterilization and disinfectants are a vital component for infection-control as medical devices require sterilization and disinfection after usage, since they get contaminated. The global market for sterilization equipment and disinfectants has been estimated to grow at the rate of 8.5% during the forecast period 2013 to 2019. Rising geriatric population is one of the primary factor for the growth of this market as they usually suffer from various diseases that leads to the need for diagnosis and treatment.In addition, increasing number of surgeries performed and per capita healthcare expenditure coupled with rising incidences of nosocomial infections (hospital-acquired infections) will propel the demand of sterilization equipment and disinfectants market.
The report describes the usage and types of sterilization equipment and disinfectants, amongst which sterilization equipment market accounted for the largest share (over 70%) of the total market in terms of revenue. Sterilization equipment market is expected to grow at the highest CAGR of 9.1% during the forecast period 2013 to 2019. This growth is attributed to their wide application area and user-friendly nature. In addition, they are safer to utilize as compared todisinfectants.




The sterilization equipment market has been further segmented as heat sterilization equipment, low temperature sterilization equipment, filtration sterilization and radiation sterilization. Low temperature sterilization equipment market is expected to grow at the highest CAGR of 10.9% during the forecast period 2013 to 2019. This growth is attributed to the increasing number of low temperature sterilization equipment manufacturers. Also, these equipment are efficient in sterilizing devices precisely with less time consumption.
The market for disinfectants has been segmented as low, intermediate and high level and oxidizing and non-oxidizing disinfectants. Low, intermediate and high level disinfectants market is expected to grow at the highest CAGR of 7.0% during the forecast period 2013 to 2019. This is due to the presence of large number of companies manufacturing theseparticular disinfectants. Also, the application area is wider unlike oxidizing and non-oxidizing disinfectants whose scope is limited to the pharmaceutical sector.


Browse all Medical Devices Market Research Reports @http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html


Sterilization equipment and disinfectants are utilized in three major application areas namely medical devices, life-sciences and pharmaceutical companies. The market for sterilization equipment and disinfectants in medical devices application accounted for the largest share (60.8%) of the total market in 2012 and is expected to grow at the highest CAGR during the forecast period. This growth is attributed due to rising incidences of hospital-acquired infections and increase in the number of surgeries performed.




The North American region accounted for the largest share in terms of revenue of the total market for sterilization equipment and disinfectants. This large market is due to increasing geriatric population. Also, the major players of the market are based here.
The global sterilization equipment and disinfectants market is ruled by players such as STERIS Corporation, Getinge Group, Advanced Sterilization Products Services, Inc., 3M and Belimed, Inc. These companies together accounted for around 70% of the total market revenue in 2012. Some other important players operating in the market include Cantel Medical, Nordion, Inc., Synergy Health plc, SAKURA SI CO., LTD., CISA Group and TSO3, Inc.


Continuous Glucose Monitoring Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

According to a new market report published by Transparency Market Research "Continuous Glucose Monitoring Market  - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global continuous glucose monitoring market was valued at USD 0.37 billion in 2012 and is expected to grow at a CAGR of 13.6% from 2013 to 2019, to reach an estimated value of USD 0.91 billion in 2019. Continuous glucose monitoring systems (CGMS) are real time glucose monitoring devices that measure and display the glucose level of the interstitial fluid in the skin cells of the patient. These devices help patients manage diabetes (Type 1 and Type 2) in a more efficient manner.


Browse the Continuous Glucose Monitoring Market Report with Full TOC at http://www.transparencymarketresearch.com/continuous-glucose-monitoring.html


CGM devices typically comprise a sensor, transmitter and a receiver. The sensor is placed underneath the skin for monitoring glucose levels and is attached to the transmitter that relays the information to the monitor. Until recently, management of diabetes involved the use of conventional blood glucose meters that provided a single time snapshot of the patient's blood glucose level. However, demand for real time monitoring, minimally invasive and effective diabetes management solutions led to the advent of CGM devices. Rise in the incidence of diabetes globally coupled with increasing awareness of such devices that possess the ability to detect hyper and hypoglycemic events in real time will fuel the growth of this market during the forecast period.




CGM is a rapidly evolving market supported by increasing adoption of these systems by hospitals and individual practitioners who further encourage their patients to use these devices. However, CGM systems are not meant to be replaced by the traditional diabetes management devices. Hence, the technology still requires innovation in terms of accuracy and precision. Reimbursement issues, high cost of devices and low market penetration rates are some of the factors that are expected to hinder market growth in the near future. Medtronic's Guardian Real Time CGM System accounted for the largest share of the global marketin 2012, accounting for a share of over 40%. The product's first mover advantage in the market, proper positioning and marketing of the product, and ease of convenience and usability helped it achieve this leadership position. Dexcom's fourth generation product, namely, Dexcom G4 Platinum is anticipated to witness the highest market growth at a CAGR of 22.6% during the forecast period. G4 Platinum is the most recently launched device (2012) and is the most technologically advanced, offering more accuracy and reliability as compared to other commercially available devices. In addition, integration of this device with insulin pumps from various other manufacturers like Johnson & Johnson and Tandem Diabetes Care would also drive the growth of this market segment.


Browse all Medical Devices Market Research Reports @http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html


Geographically, North America captured majority share of the global continuous glucose monitoring market in 2012. Increase in type I diabetic population along with rise in geriatric population which will in turn spur the demand for regular monitoring of glucose levels will fuel the growth of this market. Major players of this market are domiciled in this region, which allows easy market penetration and will also contribute towards market growth. The European CGM market is in a rapidly evolving state and contributed the largest share of the total CGM market revenue in 2012. Asia-Pacific is expected to witness tremendous increase its market share and emerge as the fastest growing region, reporting a CAGR of 16.9% during the forecast period. Economic developments, presence of a large patient pool, rising patient awareness, increasing disposable income and changing lifestyle are some of the significant factors that are poised to increase the demand for CGM systems in this region.


Tuesday 24 June 2014

Laboratory Information System Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019


According to a new market report published by Transparency Market Research "Laboratory Information System Market (Application Based- Clinical Diagnostics LIS and Drug Delivery LIS; Delivery Based- Web Based Technology, On-premise Technology and Cloud Based Technology; Component Based- Hardware, Software and Services) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019", the global Laboratory Information System market was valued at USD 1,381.4 billion in 2013 and is expected to grow at a CAGR of 7.7% from 2013 to 2019, to reach an estimated value of USD 2,158.0 billion in 2019.



Browse the full Laboratory Information System Market Report at http://www.transparencymarketresearch.com/laboratory-information-systems.html



Globally, improvement in healthcare services is playing a major role in increasing the demand for laboratory information system. As a result, this market is expected to grow at a CAGR of about 7.7% during 2013 - 2019.
Some of the key driving factors for the laboratory information system market are increasing need for integrated healthcare information systems, rising government initiatives and rising investments by healthcare IT players. However, the market faces some restraints such as lack of experienced professionals, high maintenance and service expenses and interoperability issues. The laboratory information system market is also witnessing the use of mobile phones. Also, companies are focusing on new product launches.






North America has the largest laboratory information system market and Europe is the fastest growing laboratory information system market.  Some of the fastest growing markets for laboratory information system market are Japan, Germany, U.S. and U.K.. Emerging markets, which hold huge potential and increasing demand for powerful IT systems in diagnostic and medical laboratories are some of the major opportunities for the laboratory information systems market.
Clinical diagnostics laboratory information system has the largest market share on the basis of its applications and is expected to grow at a CAGR of about 8.9% during 2013 - 2019. On the basis of its mode of delivery, the market can be classified into web based technology, on-premise technology and cloud based technology market for laboratory information systems.






McKesson Corporation is the leading player in the laboratory information systems market. Other major players of laboratory information systems market include Merge Healthcare Incorporated, Cerner Corporation and others.


Monday 23 June 2014

Cell Separation Technologies Market is expected to reach USD 3.3 Billion Globally in 2019

According to a new market report published by Transparency Market Research “Cell Separation Technologies Market (Technology: Gradient Centrifugation, MACS and FACS; Application: Stem Cell Research, Immunology, Neuroscience and Cancer Research) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019”, the global cell separation technologies market was valued at USD 1.7 billion in 2012 and is expected to grow at a CAGR of 9.7% from 2013 to 2019, to reach an estimated value of USD 3.3 billion in 2019.


Browse the Cell Separation Technologies Market Research Report with full TOC at http://www.transparencymarketresearch.com/cell-separation-technologies.html


Cells play an important role in the field of microbiology, biotechnology and bioscience which have wide application in pharmaceuticals and healthcare industries. Taking into consideration the increasing demand for cell therapies to treat chronic diseases, research activities targeting cellular therapies have increased tremendously in the last decade. Growth in cell therapy oriented research has escalated demand for cell separation technologies worldwide.




Out of the various types of technologies available in the market, magnetic activated cell sorting (MACS) technology was the major technology segment in 2012, with market share of more than 42.5% in the global cell separation technologies market. Further, fluorescence activated cell sorting (FACS) technology is estimated to capture the market share of rest of the technology segments during the forecast period owing to increased adoption of fluorescence activated cell sorting technology into cell purity sensitive research areas. It is estimated that the global FACS market will reach USD 1,078.5 billion in 2019 growing at a CAGR of 13.9% from 2013 to 2019.

Stem cell research was the major application segment by revenue in the cell separation technologies market in the year 2012. Rising demand for cell therapy and predictable potential of stem cells in the chronic disease treatment have raised the stem cell research activities globally and thereby has resulted in swift growth of the overall cell separation technologies market.




Geographically, North America was the market leader in the global cell separation technologies market in 2012 mainly owing to availability of research funds, highly developed research infrastructure and higher rates of adoption of newer technologies in the practice. Further, growth of the North American cell separation technologies market is driven by factors such as technological advancement, higher healthcare spending and availability of supportive economy to conduct research. In addition, Asia-Pacific is estimated to be a potential market due to rapidly developing healthcare infrastructure on the basis of rapidly increasing medical tourism industry in the Asian countries, mainly in India and Malaysia, increased government support for biotech research and development and large pool of patients suffering from chronic diseases. Some of the key participants operating in this market include BD Bioscience, EMD Millipore, Mitenyi Biotec GmbH, and STEMCELL Technologies and Life Technologies


Tuesday 10 June 2014

Defibrillators Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

According to a new market report published by Transparency Market Research "Defibrillators Market (Advanced Life Support, Automated External Defibrillators, Implantable Cardioverter Defibrillators, Wearable Defibrillators) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global defibrillators market was valued at USD 9.3 billion in 2012 and is expected to grow at a CAGR of 6.2% from 2013 to 2019, to reach an estimated value of USD 14.2billion in 2019.

Browse the Global Defibrillators Market Report with Full TOC: http://www.transparencymarketresearch.com/defibrillators-market.html

Defibrillator devices are used to treat life-threatening cardiac arrhythmias, particularly ventricular fibrillation and pulseless ventricular tachycardia. These devices provide an electrical shock, having energy 40 - 400 Joule to the heart muscles, which terminates the arrhythmia and restores the normal sinus rhythm in the heart. Since the defibrillator devices are very useful in preventing deaths due to sudden cardiac arrest (SCA), the large number of SCA incidences across the globe is the major driver for the growth of this market.

Growing incidences of cardiovascular diseases and disorders combined with aging of baby boomer population in the U.S. are contributing to the growth of the global defibrillators market. Furthermore, the market is more driven by demand from emerging countries from Asia-Pacific and the Middle-East. Increasing trend towards installations of AEDs at workplaces by businesses is expected to serve as a good opportunity for the growth of global defibrillators market.



The global defibrillators market has been segmented on the basis of product types, end-users and geographic regions. On the basis of defibrillator types, the market is divided into advanced life support (ALS) defibrillators, automated external defibrillators (AEDs), implantable cardioverter defibrillators (ICDs) and wearable defibrillators. In 2012, implantable defibrillator devices accounted for the largest share by revenue of the global defibrillators followed by ALS defibrillators. The global rise in the healthcare infrastructure which include state-of-the-art hospitals and ambulances equipped with advanced medical devices is seen as a driver for ALS defibrillator segment.


The report also provides market estimations for the end-users of defibrillator devices during the forecast period of 2013 to 2019. The market has been categorized on the basis of end-users into five major segments, namely, hospitals, home, public access, emergency medical services and business workplace. In 2012, the hospitals as an end-user category shared more than 90%of the global defibrillator market. Other segments which are expected to grow rapidly during the forecast period are public access and business workplace. The government initiatives for creating awareness about the usefulness of AEDs in SCA will be the crucial factor for the growth of this market. Although the FDA initiatives to tighten the AED approval process, through pre-market approval (PMA), are likely to impact the market negatively, the grace period implementing changes is considerable enough for manufacturers in the defibrillators market.



Geographically, North America is the largest market for defibrillator devices and is expected to retain its top position throughout the forecast period. The rising awareness about the SCA and defibrillators in the USA and Canada is contributing to overall growth of defibrillators market in the region. In addition, legislation requiring installation of AEDs for public access and 'Samaritan Laws' providing immunity to first responders are driving factors for the market. Europe was the second largest market for defibrillator devices in 2012. During the forecast period, 2013 to 2019, Asia-Pacific and Middle-East are expected to grow at a faster pace than North America and Europe owing to the large patient base, increasing incidences of cardiovascular diseases and rising per capita expenditure on healthcare. The strengthening of economies in the Asia-Pacific and the subsequent rise in the healthcare infrastructure are propelling the market for defibrillators in this region.

Monday 9 June 2014

Surgical Equipment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

Medical Devices Market
According to Transparency Market Research “Surgical Equipment Market (Surgical Sutures, Surgical Hand Instruments, and Electrosurgical Devices) – Global Forecast, Market Share, Size, Growth and Industry Analysis (2010 – 2017)”; the global Transparency Market Research surgical equipment market was worth USD 5.2 billion in 2011 and is forecasted to reach USD 7.5 billion in 2017 at a CAGR of 6.2% from 2011 to 2017. Surgical sutures segment accounted for the largest share – i.e. 57.0% of the global surgical equipment market at USD 3.0 billion in 2011. The electrosurgical devices segment will have the fastest revenue growth at a CAGR of 7.5% during 2011 – 2017.


The global surgical equipment market is divided into three categories: electrosurgical devices, hand instruments and surgical suture. The surgical equipment industry is composed of mechanical devices (such as lasers, electro-surgery devices, disposables, heavier cutting tools, generators and accessories), handheld instruments (blades, scalpels, clamps and scissors) and wound closure products such sutures (non-absorbable and absorbable).


The surgical equipment market is driven by strong economic growth in Japan, Europe and in emerging economies such as India and China. Increased healthcare expenditure, improving standards of living and longer life expectancies are the major factors driving the growth of the surgical equipment market. Moreover, growing demand of outpatient surgeries, increase in the number of healthcare centers, the rise in the surgical procedures performed globally; technological innovations and growing preference for minimally invasive surgeries are also driving the growth of the surgical equipment market.
Our research indicates faster growth in number of surgical performed in emerging economies in comparison with developed economies. This is primarily due to the higher economic growth and fast improving healthcare facilities in these economies, and declining repayment levels in the U.S.

Browse all Medical Devices Market Research Reports at http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html

High competition in the global surgical equipment market is observed with local and international players capturing respective slice of the surgical pie. The faster addition of operating facilities compounded with growing number of hospitals in emerging economies provides healthy growth opportunities for established as well as new players. The top four players in the global surgical equipment market accounted for about 64% market share in 2011. Ethicon was the clear leader in the global surgical equipment market accounting for 34.4% market share in 2011.

This report is an effort to identify driving forces behind the global and regional surgical equipment market over the next six years.

Wednesday 4 June 2014

Deep Brain Stimulation Devices Market : Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

According to a new market report published by Transparency Market Research "Deep Brain Stimulation Devices Market for Parkinson's Disease (North America, Europe, Asia-Pacific and Latin America)- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global deep brain stimulation devices market was valued at USD 4.5 billion in 2012 and is expected to grow at a CAGR of 11.0% from 2013 to 2019, to reach an estimated value of USD 9.4 billion in 2019.

Browse Global Deep Brain Stimulation Devices Market Report with Full TOC at http://www.transparencymarketresearch.com/deep-brain-stimulator-market.html

Rising number of neurological disorders such ischemic stroke, Alzheimer's disease, essential tremors, trauma and especially Parkinsonism are primary factors responsible for the growth of deep brain stimulation devices market. Parkinson's disease is the second most common chronic and progressive neurodegenerative disorder characterized by postural instability, bradykinesia, akinesia and tremors due to loss of dopamine producing neurons in substantia nigra of mid-brain.

In addition, rise in geriatric population along with augmented demand for minimally invasive surgical techniques have boosted the overall growth of this market. Moreover, increase in preference of patients and healthcare professionals to adopt surgical DBS devices over drug therapy owing to its significantside effects and lack of effectiveness is further expected to drive the market in coming years.


According to the Parkinson's DiseaseFoundation (PDF), it has been estimated that approximately 10 million people worldwide and one million Americans are living with Parkinson's disease. Among these, in U.S. approximately 60,000 people are diagnosed with Parkinson's disease each year. There are different treatment options available for Parkinson's disease that include drug therapy, surgical therapy, physical therapy and stem cell therapy. However, DBS surgical therapy is mostly preferred in advanced stages of the disease while in early stages chemotherapy is used.

Browse all Medical Devices Market Research Reports at http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html

The global deep brain stimulation devices market is segmented geographically into North America, Europe, Asia-Pacific andLatin America. Among these, North America accounts for the largest market share of deep brain stimulation devices market and is valued to be more than USD 2billion in 2012 owing to rise in number of patients who are adopting surgical therapy for Parkinson's disease and rise in geriatric population. In addition, favorable government reimbursement policies and growing side effects from medication treatment are further expected toboost the growth of the market in this region. The market for North America is followed by Europe, Latin America and Asia-Pacific. Contributing factors for the lowest market share of deep brain stimulation devices in Asia-Pacific include lack of favorable government insurance policies and high cost for surgical treatment.



The major players of this market include Medtronic, Inc., St. Jude Medical, Inc. and Boston Scientific Corporation. Other companies active in this market include Sapiens Neuro, Aleva Neurotherapeutics SA, ANM Adaptive Neuromodulation GmbH, Synaptix, Neurosigma, Inc. and Neurospace. The DBS products of these "Other" players are not yet commercially available in the market since they are still under clinical trials. Companies are heavily focusing on introducing innovative products that are easy to use for physicians as well as patients. These companies are also aiming to make them more portable.